Product correctly added to cart.

discount label
3-Bromo-4,5-dihydroxybenzonitrile
View 3D

Biosynth logo

3-Bromo-4,5-dihydroxybenzonitrile

CAS: 38897-25-5

Ref. 3D-NBA89725

1gTo inquire
500mgTo inquire
Estimated delivery in United States, on Monday 26 Aug 2024

Product Information

Name:
3-Bromo-4,5-dihydroxybenzonitrile
Description:

3-Bromo-4,5-dihydroxybenzonitrile is a molecule that has been found to be effective in treating neurodegenerative diseases. It has been shown to inhibit gene transcription, leading to the inhibition of cell proliferation and apoptosis. This drug also inhibits N-acetylglucosamine glycosylase, an enzyme that is involved in the removal of the amino group from cellular glycerophospholipids. 3-Bromo-4,5-dihydroxybenzonitrile binds to the hydrophobic pocket of DNA and prevents the formation of hydrogen bonds with the nucleobases. 3-Bromo-4,5-dihydroxybenzonitrile is a cochlear toxicant as it can cause hearing loss and deafness when administered at high doses. The cochlear toxicity may be due to its ability to inhibit tyrosine kinase activity, protein phosphatase 2

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
214.02 g/mol
Formula:
C7H4BrNO2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-NBA89725 3-Bromo-4,5-dihydroxybenzonitrile

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".